Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             95 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 Adenovirus 5 and 35 vectors expressing Plasmodium falciparum circumsporozoite surface protein elicit potent antigen-specific cellular IFN-γ and antibody responses in mice Shott, Joseph P.
2008
26 Supplement 5 p. 2818-2823
6 p.
artikel
2 Age for HPV vaccination Harper, Diane M.
2008
26 Supplement 5 p. A7-A11
nvt p.
artikel
3 Age-related trends in the timeliness and prediction of medical visits, hospitalizations and deaths due to pneumonia and influenza, British Columbia, Canada, 1998–2004 Sebastian, R.
2008
26 Supplement 5 p. 1397-1403
7 p.
artikel
4 Alpha C protein-specific immunity in humans with group B streptococcal colonization and invasive disease Pannaraj, Pia S.
2008
26 Supplement 5 p. 502-508
7 p.
artikel
5 An in vivo passive protection assay for the evaluation of immunity in AVA-vaccinated individuals Hewetson, John F.
2008
26 Supplement 5 p. 4262-4266
5 p.
artikel
6 A novel bi-functional DNA vaccine expressing VP1 protein and producing antisense RNA targeted to 5′UTR of foot-and-mouth disease virus can induce both rapid inhibitory effect and specific immune response in mice Yang, Bin
2008
26 Supplement 5 p. 5477-5483
7 p.
artikel
7 A Phase 1 trial of PfCP2.9: An AMA1/MSP1 chimeric recombinant protein vaccine for Plasmodium falciparum malaria Malkin, Elissa
2008
26 Supplement 5 p. 6864-6873
10 p.
artikel
8 A recombinant pseudorabies virus expressing rabies virus glycoprotein: Safety and immunogenicity in dogs Yuan, Ziguo
2008
26 Supplement 5 p. 1314-1321
8 p.
artikel
9 Assessing the impact of different BCG vaccination strategies on severe childhood TB in low-intermediate prevalence settings Manissero, Davide
2008
26 Supplement 5 p. 2253-2259
7 p.
artikel
10 Associations between SNPs in toll-like receptors and related intracellular signaling molecules and immune responses to measles vaccine: Preliminary results Dhiman, Neelam
2008
26 Supplement 5 p. 1731-1736
6 p.
artikel
11 A vaccine prepared from a non-pathogenic H5N1 avian influenza virus strain confers protective immunity against highly pathogenic avian influenza virus infection in cynomolgus macaques Itoh, Yasushi
2008
26 Supplement 5 p. 562-572
11 p.
artikel
12 Avian coronavirus infectious bronchitis attenuated live vaccines undergo selection of subpopulations and mutations following vaccination McKinley, Enid T.
2008
26 Supplement 5 p. 1274-1284
11 p.
artikel
13 A 5-year follow-up of antibody response in children vaccinated with single dose of live attenuated SA14-14-2 Japanese encephalitis vaccine: Immunogenicity and anamnestic responses Sohn, Young Mo
2008
26 Supplement 5 p. 1638-1643
6 p.
artikel
14 Bath vaccination of rainbow trout (Oncorhynchus mykiss Walbaum) against Yersinia ruckeri: Effects of temperature on protection and gene expression Raida, M.K.
2008
26 Supplement 5 p. 1050-1062
13 p.
artikel
15 Combination of treatment with death receptor 5-specific antibody with therapeutic HPV DNA vaccination generates enhanced therapeutic anti-tumor effects Tseng, Chih Wen
2008
26 Supplement 5 p. 4314-4319
6 p.
artikel
16 Correlation of immunogenicities and in vitro expression levels of recombinant modified vaccinia virus Ankara HIV vaccines Wyatt, Linda S.
2008
26 Supplement 5 p. 486-493
8 p.
artikel
17 Cost-effectiveness of Japanese encephalitis (JE) immunization in Bali, Indonesia Liu, Wei
2008
26 Supplement 5 p. 4456-4460
5 p.
artikel
18 Cross-protection by MF59™-adjuvanted influenza vaccine: Neutralizing and haemagglutination-inhibiting antibody activity against A(H3N2) drifted influenza viruses Ansaldi, Filippo
2008
26 Supplement 5 p. 1525-1529
5 p.
artikel
19 DNA sequence analysis of varicella-zoster virus gene 62 from subclinical infections in healthy children immunized with the Oka varicella vaccine Gomi, Yasuyuki
2008
26 Supplement 5 p. 5627-5632
6 p.
artikel
20 Editorial Board 2008
26 Supplement 5 p. CO2-
1 p.
artikel
21 Editorial Board 2008
26 Supplement 5 p. CO2-
1 p.
artikel
22 Editorial Board/Aims and Scope 2008
26 Supplement 5 p. CO2-
1 p.
artikel
23 Editorial Board/Aims and Scope 2008
26 Supplement 5 p. CO2-
1 p.
artikel
24 Editorial Board/Aims and Scope 2008
26 Supplement 5 p. CO2-
1 p.
artikel
25 Effective and safe immunizations with live-attenuated vaccines for children after living donor liver transplantation Shinjoh, Masayoshi
2008
26 Supplement 5 p. 6859-6863
5 p.
artikel
26 Effectiveness of a 2+1 dose schedule pneumococcal conjugate vaccination programme on invasive pneumococcal disease among children in Norway Vestrheim, Didrik F.
2008
26 Supplement 5 p. 3277-3281
5 p.
artikel
27 Effectiveness of hexavalent vaccines against invasive Haemophilus influenzae type b disease: Germany's experience after 5 years of licensure Kalies, Helen
2008
26 Supplement 5 p. 2545-2552
8 p.
artikel
28 Elective termination of pregnancy after vaccination reported to the Vaccine Adverse Event Reporting System (VAERS): 1990–2006 Chang, Soju
2008
26 Supplement 5 p. 2428-2432
5 p.
artikel
29 Estimated effect of pneumococcal conjugate vaccination on invasive pneumococcal disease and associated mortality, Denmark 2000–2005 Harboe, Zitta B.
2008
26 Supplement 5 p. 3765-3771
7 p.
artikel
30 Evaluation of a measles vaccine campaign in Ethiopia using oral-fluid antibody surveys Nigatu, Wondatir
2008
26 Supplement 5 p. 4769-4774
6 p.
artikel
31 Evaluation of the pathogenicity of African Horsesickness (AHS) isolates in vaccinated animals von Teichman, Beate F.
2008
26 Supplement 5 p. 5014-5021
8 p.
artikel
32 Evaluation of widely consumed botanicals as immunological adjuvants Ragupathi, Govind
2008
26 Supplement 5 p. 4860-4865
6 p.
artikel
33 Experimental use of the attenuated Ehrlichia ruminantium (Welgevonden) vaccine in Merino sheep and Angora goats Zweygarth, Erich
2008
26 Supplement 5 p. G34-G39
nvt p.
artikel
34 Exploring the cost-effectiveness of HPV vaccination in Vietnam: Insights for evidence-based cervical cancer prevention policy Kim, Jane J.
2008
26 Supplement 5 p. 4015-4024
10 p.
artikel
35 Gene profiling analysis of ALVAC infected human monocyte derived dendritic cells Harenberg, Anke
2008
26 Supplement 5 p. 5004-5013
10 p.
artikel
36 Health and economic outcomes of HPV 16,18 vaccination in 72 GAVI-eligible countries Goldie, Sue J.
2008
26 Supplement 5 p. 4080-4093
14 p.
artikel
37 Identification of immunodominant T-cell epitopes present in glycoprotein 5 of the North American genotype of porcine reproductive and respiratory syndrome virus Vashisht, Kapil
2008
26 Supplement 5 p. 4747-4753
7 p.
artikel
38 Immunogenicity and safety of aerosolized measles vaccine: Systematic review and meta-analysis Low, Nicola
2008
26 Supplement 5 p. 383-398
16 p.
artikel
39 Immunogenicity and safety of three consecutive lots of a new preservative-free inactivated hepatitis A vaccine (Healive®): A double-blind, randomized and controlled trial Jiang, Wei-Ping
2008
26 Supplement 5 p. 2297-2301
5 p.
artikel
40 Immunogenicity and serotype-specific efficacy of a 9-valent pneumococcal conjugate vaccine (PCV-9) determined during an efficacy trial in The Gambia Saaka, M.
2008
26 Supplement 5 p. 3719-3726
8 p.
artikel
41 Immunogenicity, reactogenicity, and safety of a seven-valent pneumococcal conjugate vaccine (PCV7) concurrently administered with a fully liquid DTPa–IPV–HBV–Hib combination vaccine in healthy infants Olivier, C.
2008
26 Supplement 5 p. 3142-3152
11 p.
artikel
42 Impact and effectiveness of a mass hepatitis A vaccination programme of preadolescents seven years after introduction Domínguez, A.
2008
26 Supplement 5 p. 1737-1741
5 p.
artikel
43 Inexpensive anti-cysticercosis vaccine: S3Pvac expressed in heat inactivated M13 filamentous phage proves effective against naturally acquired Taenia solium porcine cysticercosis Morales, Julio
2008
26 Supplement 5 p. 2899-2905
7 p.
artikel
44 Influence of the Ixodes ricinus tick blood-feeding on the antigen-specific antibody response in vivo Menten-Dedoyart, C.
2008
26 Supplement 5 p. 6956-6964
9 p.
artikel
45 Influenza vaccine strain selection and recent studies on the global migration of seasonal influenza viruses Russell, Colin A.
2008
26 Supplement 5 p. D31-D34
nvt p.
artikel
46 Introduction of Human Papillomavirus Vaccines into Developing Countries - International Strategies for Funding and Procurement Andrus, Jon Kim
2008
26 Supplement 5 p. K87-K92
nvt p.
artikel
47 Invasive Pneumococcal disease in Singapore children Chong, Chia-Yin
2008
26 Supplement 5 p. 3427-3431
5 p.
artikel
48 In vivo oral administration effects of various oligodeoxynucleotides containing synthetic immunostimulatory motifs in the immune response to pseudorabies attenuated virus vaccine in newborn piglets Linghua, Zhang
2008
26 Supplement 5 p. 224-233
10 p.
artikel
49 Issues with reducing the rotavirus-associated mortality by vaccination in developing countries Naghipour, Mohammadreza
2008
26 Supplement 5 p. 3236-3241
6 p.
artikel
50 Long-term antibody persistence in children primed and boosted with a DTPw-HBV vaccine at 2, 4, 6, 18, months of age Poovorawan, Yong
2008
26 Supplement 5 p. 1535-1540
6 p.
artikel
51 Low dose revaccination induces robust protective anti-HBs antibody response in the majority of healthy non-responder neonates Jafarzadeh, A.
2008
26 Supplement 5 p. 269-276
8 p.
artikel
52 Mathematical Models of Cervical Cancer Prevention in Latin America and the Caribbean Goldie, Sue J.
2008
26 Supplement 5 p. L59-L72
nvt p.
artikel
53 Mathematical Models of Cervical Cancer Prevention in the Asia Pacific Region Goldie, Sue J.
2008
26 Supplement 5 p. M17-M29
nvt p.
artikel
54 Nef modulates the immunogenicity of Gag encoded in a non-infectious HIV DNA vaccine Arrode, Geraldine
2008
26 Supplement 5 p. 3795-3804
10 p.
artikel
55 New malaria vaccine candidates based on the Plasmodium vivax Merozoite Surface Protein-1 and the TLR-5 agonist Salmonella Typhimurium FliC flagellin Bargieri, Daniel Y.
2008
26 Supplement 5 p. 6132-6142
11 p.
artikel
56 Open-label, dose escalation phase I study in healthy volunteers to evaluate the safety and pharmacokinetics of a human monoclonal antibody to Clostridium difficile toxin A Taylor, Claribel P.
2008
26 Supplement 5 p. 3404-3409
6 p.
artikel
57 Open-label trial of therapeutic immunization with oral V-5 Immunitor (V5) vaccine in patients with chronic hepatitis C Batdelger, Dendev
2008
26 Supplement 5 p. 2733-2737
5 p.
artikel
58 Oral vaccination of dogs (Canis familiaris) with baits containing the recombinant rabies-canine adenovirus type-2 vaccine confers long-lasting immunity against rabies Zhang, Shoufeng
2008
26 Supplement 5 p. 345-350
6 p.
artikel
59 Parent-collected respiratory specimens—A novel method for respiratory virus and vaccine efficacy research Lambert, Stephen B.
2008
26 Supplement 5 p. 1826-1831
6 p.
artikel
60 Parenteral administration of RF 8-2/6/7 rotavirus-like particles in a one-dose regimen induce protective immunity in mice Istrate, Claudia
2008
26 Supplement 5 p. 4594-4601
8 p.
artikel
61 Phase 2a trial of 0, 1, and 3 month and 0, 7, and 28 day immunization schedules of malaria vaccine RTS,S/AS02 in malaria-naïve adults at the Walter Reed Army Institute of Research Kester, Kent E.
2008
26 Supplement 5 p. 2191-2202
12 p.
artikel
62 Plant-expressed HA as a seasonal influenza vaccine candidate Shoji, Yoko
2008
26 Supplement 5 p. 2930-2934
5 p.
artikel
63 Polylactide-co-glycolide (PLG) microparticles modify the immune response to DNA vaccination Helson, Rebecca
2008
26 Supplement 5 p. 753-761
9 p.
artikel
64 Poor immunogenicity of BCG in helminth infected population is associated with increased in vitro TGF-β production Elias, Daniel
2008
26 Supplement 5 p. 3897-3902
6 p.
artikel
65 Post-exposure prophylaxis (PEP) of rabies-infected Indian street dogs Manickam, R.
2008
26 Supplement 5 p. 6564-6568
5 p.
artikel
66 Potential of Mw as a prophylactic vaccine against pulmonary tuberculosis Katoch, K.
2008
26 Supplement 5 p. 1228-1234
7 p.
artikel
67 Predicted long-term persistence of pertussis antibodies in adolescents after an adolescent and adult formulation combined tetanus, diphtheria, and 5-component acellular pertussis vaccine, based on mathematical modeling and 5-year observed data Bailleux, F.
2008
26 Supplement 5 p. 3903-3908
6 p.
artikel
68 Prediction of pertussis vaccine efficacy using a correlates of protection model Kohberger, Robert C.
2008
26 Supplement 5 p. 3516-3521
6 p.
artikel
69 Protection of guinea pigs and swine by a recombinant adenovirus expressing O serotype of foot-and-mouth disease virus whole capsid and 3C protease Lu, Zengjun
2008
26 Supplement 5 p. G48-G53
nvt p.
artikel
70 Protective effects of recombinant staphylococcal enterotoxin type C mutant vaccine against experimental bovine infection by a strain of Staphylococcus aureus isolated from subclinical mastitis in dairy cattle Chang, Byoung Sun
2008
26 Supplement 5 p. 2081-2091
11 p.
artikel
71 Protective efficacy of a recombinant subunit West Nile virus vaccine in domestic geese (Anser anser) Jarvi, Susan I.
2008
26 Supplement 5 p. 5338-5344
7 p.
artikel
72 Protective immune response in mice vaccinated with a recombinant adenovirus containing capsid precursor polypeptide P1, nonstructural protein 2A and 3C protease genes (P12A3C) of encephalomyocarditis virus Chen, Zhenhai
2008
26 Supplement 5 p. 573-580
8 p.
artikel
73 Protective immunity against challenge with Leishmania (Leishmania) chagasi in beagle dogs vaccinated with recombinant A2 protein Fernandes, Ana Paula
2008
26 Supplement 5 p. 5888-5895
8 p.
artikel
74 Protective immunity with an E1 multivalent epitope DNA vaccine against cottontail rabbit papillomavirus (CRPV) infection in an HLA-A2.1 transgenic rabbit model Hu, Jiafen
2008
26 Supplement 5 p. 809-816
8 p.
artikel
75 Reactogenicity of infant whole cell pertussis combination vaccine compared with acellular pertussis vaccines with or without simultaneous pneumococcal vaccine in the Netherlands David, Silke
2008
26 Supplement 5 p. 5883-5887
5 p.
artikel
76 Relationship between occurrence of Guillain-Barre syndrome and mass campaign of measles and rubella immunization in Iranian 5–14 years old children Esteghamati, Abdoulreza
2008
26 Supplement 5 p. 5058-5061
4 p.
artikel
77 Safety and efficacy of live attenuated influenza vaccine in children 2–7 years of age Belshe, Robert B.
2008
26 Supplement 5 p. D10-D16
nvt p.
artikel
78 Safety and immunogenicity of a DTaP-IPVVero (serum-free) combination vaccine in comparison to DTaP-IPVMkc when administered simultaneously with Haemophilus influenzae type b conjugate vaccine (PRP-T) in children at 2, 3.5, 5 and 16 months of age Pietrzyk, Jacek J.
2008
26 Supplement 5 p. 5296-5303
8 p.
artikel
79 Safety and immunogenicity of a 7-valent pneumococcal conjugate vaccine (Prevenar™): Primary dosing series in healthy Chinese infants Li, Rong Cheng
2008
26 Supplement 5 p. 2260-2269
10 p.
artikel
80 Safety and immunogenicity of CRM197-conjugated pneumococcal–meningococcal C combination vaccine (9vPnC–MnCC) whether given in two or three primary doses Sigurdardottir, Sigurveig Th.
2008
26 Supplement 5 p. 4178-4186
9 p.
artikel
81 Safety and immunogenicity of two subunit influenza vaccines in healthy children, adults and the elderly: A randomized controlled trial in China Zhu, Feng Cai
2008
26 Supplement 5 p. 4579-4584
6 p.
artikel
82 Safety of the 11-valent pneumococcal vaccine conjugated to non-typeable Haemophilus influenzae-derived protein D in the first 2 years of life and immunogenicity of the co-administered hexavalent diphtheria, tetanus, acellular pertussis, hepatitis B, inactivated polio virus, Haemophilus influenzae type b and control hepatitis A vaccines Prymula, Roman
2008
26 Supplement 5 p. 4563-4570
8 p.
artikel
83 Scalable culture systems using different cell lines for the production of Peste des Petits ruminants vaccine Silva, Ana Carina
2008
26 Supplement 5 p. 3305-3311
7 p.
artikel
84 Selection of serotype-specific vaccine candidate genes in Actinobacillus pleuropneumoniae and heterologous immunization with Propionibacterium acnes Lei, Liancheng
2008
26 Supplement 5 p. 6274-6280
7 p.
artikel
85 Shedding and immunogenicity of live attenuated influenza vaccine virus in subjects 5–49 years of age Block, Stan L.
2008
26 Supplement 5 p. 4940-4946
7 p.
artikel
86 Shedding of live vaccine virus, comparative safety, and influenza-specific antibody responses after administration of live attenuated and inactivated trivalent influenza vaccines to HIV-infected children Levin, Myron J.
2008
26 Supplement 5 p. 4210-4217
8 p.
artikel
87 Sudden deaths following influenza vaccination: Can this be expected? van der Sande, M.A.B.
2008
26 Supplement 5 p. 379-382
4 p.
artikel
88 The antifertility effects of DNA vaccine-induced immune responses against uroguanylin Sun, Jing
2008
26 Supplement 5 p. 3696-3704
9 p.
artikel
89 The effectiveness of national influenza vaccination policies for at-risk populations over 5 seasons in a Scottish general practice Sivaprakasam, V.
2008
26 Supplement 5 p. 3772-3777
6 p.
artikel
90 The effect of Bacille Calmette-Guérin vaccine on tuberculin reactivity in indigenous children from communities with high prevalence of tuberculosis Araujo, Zaida
2008
26 Supplement 5 p. 5575-5581
7 p.
artikel
91 The measles campaign in West and Central Africa: Remembering the future De Groot, Annie
2008
26 Supplement 5 p. 3783-3786
4 p.
artikel
92 Therapeutic vaccination against malignant gliomas based on allorecognition and syngeneic tumor antigens: Proof of principle in two strains of rat Stathopoulos, Apostolos
2008
26 Supplement 5 p. 1764-1772
9 p.
artikel
93 Twenty-two years follow-up of a prospective randomized trial of hepatitis B vaccines without booster dose in children: Final report But, David Yiu-Kuen
2008
26 Supplement 5 p. 6587-6591
5 p.
artikel
94 Vaccination coverage and awareness of infectious risks in patients with an absent or dysfunctional spleen in the Netherlands Meerveld-Eggink, A.
2008
26 Supplement 5 p. 6975-6979
5 p.
artikel
95 Vaccine Adjuvant Systems containing monophosphoryl lipid A and QS21 induce strong and persistent humoral and T cell responses against hepatitis B surface antigen in healthy adult volunteers Vandepapelière, Pierre
2008
26 Supplement 5 p. 1375-1386
12 p.
artikel
                             95 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland